Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Post-Hoc Study Analysis Examines Early Intervention with Edaravone for ALS Survival

americanpharmaceuticalreviewMarch 25, 2021

Tag: ALS , Mitsubishi Tanabe , edaravone , MTPA , RADICAVA

PharmaSources Customer Service